Introduction to the Clinical Trial Institution for Drugs and Medical Devices

Beijing GoBroad International Research Hospital is located in Zhongguancun Life Science Park. As a key strategic project of Beijing, the Beijing GoBroad Hospital project was included in the city's "3 x 100" priority projects in 2020 and began operations in August 2023. It is the first international research-oriented hospital in China.

The hospital has eight floors above ground and three underground levels, with a total construction area of approximately 97,400 square meters. It is designed for 500 beds and includes 37 clinical and medical technology departments. Focused on complex and critical diseases and clinical translation, the hospital integrates research and clinical functions. Key facilities include a Clinical Application and Drug Development Center, an Innovation Research Center for Clinical Experts and Scientists, a Clinical Discovery and Industrial Transformation Platform, and a Complex and Critical Disease Diagnosis & Treatment Center. The hospital aims to establish a closed-loop system linking clinical discovery, basic research, industrial transformation, and clinical application.

The Clinical Trial Institution at Beijing GoBroad Hospital has a professional research team, including seven nationally renowned experts. With top principal investigators (PIs) at its core and a dedicated research team for support, it ensures clinical trials meet international standards. The institution has made significant progress in quality management, personnel training, digital infrastructure, investigational drug management, and document control. All clinical trials undergo dynamic quality control and process monitoring to ensure high-quality research outcomes.

Organizational Chart of the Clinical Trial Institution

Overview of Clinical Trials

The hospital completed the registration of its Drug Clinical Trial Institution in 2023 (Registration No.: Yao Linchuang Jigou Bei Zi 2023000160). Currently, it has a Phase I Clinical Trial Unit, Hematology Department, Pediatric Hematology, and Oncology Department. For details on specific departments and principal investigators, please refer to the [Drug Clinical Trial Institution Registration Management Information System].

https://beian.cfdi.org.cn/CTMDS/apps/pub/drugPublic.jsp

The hospital completed the registration of its Medical Device Clinical Trial Institution in 2023 (Registration No.: Xie Lin Jigou Bei 202300139). Currently, it has the Medical Laboratory Department and Oncology Department. For details on specific departments and principal investigators, please refer to the [Medical Device Clinical Trial Institution Registration Management Information System].

https://beian.cfdi.org.cn/CTMDS/apps/pub/ylqxPublic.jsp